JP2013527197A5 - - Google Patents

Download PDF

Info

Publication number
JP2013527197A5
JP2013527197A5 JP2013512249A JP2013512249A JP2013527197A5 JP 2013527197 A5 JP2013527197 A5 JP 2013527197A5 JP 2013512249 A JP2013512249 A JP 2013512249A JP 2013512249 A JP2013512249 A JP 2013512249A JP 2013527197 A5 JP2013527197 A5 JP 2013527197A5
Authority
JP
Japan
Prior art keywords
matrix
self
adhesive
item
piroxicam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013512249A
Other languages
English (en)
Japanese (ja)
Other versions
JP5948322B2 (ja
JP2013527197A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/038189 external-priority patent/WO2011150239A2/en
Publication of JP2013527197A publication Critical patent/JP2013527197A/ja
Publication of JP2013527197A5 publication Critical patent/JP2013527197A5/ja
Application granted granted Critical
Publication of JP5948322B2 publication Critical patent/JP5948322B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013512249A 2010-05-27 2011-05-26 ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法 Expired - Fee Related JP5948322B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39634710P 2010-05-27 2010-05-27
US61/396,347 2010-05-27
PCT/US2011/038189 WO2011150239A2 (en) 2010-05-27 2011-05-26 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015235438A Division JP2016033163A (ja) 2010-05-27 2015-12-02 ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法

Publications (3)

Publication Number Publication Date
JP2013527197A JP2013527197A (ja) 2013-06-27
JP2013527197A5 true JP2013527197A5 (enExample) 2014-07-10
JP5948322B2 JP5948322B2 (ja) 2016-07-06

Family

ID=44352274

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013512249A Expired - Fee Related JP5948322B2 (ja) 2010-05-27 2011-05-26 ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法
JP2015235438A Pending JP2016033163A (ja) 2010-05-27 2015-12-02 ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015235438A Pending JP2016033163A (ja) 2010-05-27 2015-12-02 ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法

Country Status (7)

Country Link
US (2) US8563031B2 (enExample)
EP (1) EP2575791B1 (enExample)
JP (2) JP5948322B2 (enExample)
CN (1) CN102970986B (enExample)
AU (1) AU2011258146A1 (enExample)
CA (1) CA2800716C (enExample)
WO (1) WO2011150239A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105764495A (zh) * 2013-10-07 2016-07-13 帝国制药美国公司 用于管理疼痛的包含右旋美托咪啶经皮组合物的方法及组合物
KR20190060007A (ko) 2016-10-31 2019-05-31 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법
CN107028921A (zh) * 2017-05-16 2017-08-11 蔡志浩 一种吡罗昔康巴布贴剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989586A (en) 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
DE69330388T2 (de) 1992-12-31 2002-01-03 Sunkyong Industries Co. Ltd., Suwon Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
WO1994023713A1 (en) 1993-04-22 1994-10-27 Minnesota Mining And Manufacturing Company Transdermal antiinflammatory composition
DE4405898A1 (de) 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
JP3305101B2 (ja) * 1994-03-29 2002-07-22 積水化学工業株式会社 経皮吸収製剤
JPH08295624A (ja) * 1995-04-26 1996-11-12 Read Chem Kk プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤
KR100294084B1 (ko) * 1998-06-02 2001-09-22 성재갑 비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
CN1195506C (zh) * 1999-11-29 2005-04-06 Lts勒曼治疗系统股份公司 具有改良稳定性的经皮治疗系统及其制备方法
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
KR100846642B1 (ko) 2001-03-07 2008-07-16 히사미쓰 세이야꾸 가부시키가이샤 첩부제
US20040127531A1 (en) * 2002-11-21 2004-07-01 Lu Guang Wei Adhesive coated sheet for dermal delivery of a selective cyclooxygenase-2 inhibitor
US20050020658A1 (en) * 2002-11-21 2005-01-27 Katsuyuki Inoo Selective cyclooxygenase-2 inhibitor patch
KR100552650B1 (ko) 2003-11-17 2006-02-20 아이큐어 주식회사 피록시캄 함유 소염진통용 플라스터
CN1882340A (zh) * 2003-11-19 2006-12-20 艾克若克斯Dds有限公司 用于治疗或预防淀粉样变性病的方法和组合物
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
DE102004062614B4 (de) * 2004-12-24 2011-12-29 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System mit aktivierbarer Übersättigung und kontrollierter Permeationförderung sowie Verfahren zu dessen Herstellung
US20080226698A1 (en) * 2007-03-16 2008-09-18 Mylan Technologies, Inc. Amorphous drug transdermal systems, manufacturing methods, and stabilization
CA2698293A1 (en) * 2007-09-13 2009-03-26 Thomas Subkowski Use of hydrophobin polypeptides as penetration intensifiers

Similar Documents

Publication Publication Date Title
JP4909892B2 (ja) 身体に治療をもたらすためのシステム及び方法
TN2015000201A1 (en) Transdermal delivery system
Durand et al. Practical considerations for optimal transdermal drug delivery
PH12015502550A1 (en) Transdermal delivery system
PH12014501231A1 (en) Transdermal delivery system comprising buprenorphine
JP2018518498A5 (enExample)
JP2016502989A5 (enExample)
MY183873A (en) Transdermal therapeutic system for application of an agent
JP2016504368A5 (enExample)
MX2012002727A (es) Sistema terapeutico transdermico para administrar fentanilo o un analogo del mismo.
WO2008027203A2 (en) Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
MX2009014102A (es) Sistema de administración transdérmica que comprende glicopirrolato para tratar sialorrea.
EA201300648A1 (ru) Трансдермальная терапевтическая система (tts), содержащая ротиготин
CN1950074A (zh) 用于为身体的部位提供治疗的具有彼此可拆卸地固定在一起的两个贴片的皮肤系统
WO2016149077A3 (en) Fentanyl transdermal delivery system
EP1962837A2 (en) Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
JP2018537451A5 (enExample)
CN108697658B (zh) 贴剂
MX2015010967A (es) Formulaciones transdermicas de laquinimod.
JP5948322B2 (ja) ピロキシカム含有マトリックスパッチ、ならびにそれを用いる急性および慢性の疼痛および炎症の局所処置の方法
WO2024189213A1 (en) Medical patch comprising skin irritating active agent
JP2011510936A5 (enExample)
JP2004315542A (ja) 外用貼付剤及び外用貼付剤中の薬物のエステル化抑制方法
TH155327A (th) ระบบรักษาโรคผ่านผิวหนังสำหรับการให้สารออกฤทธิ์
AR082906A1 (es) Parches transdermicos de dosis baja con nivel elevado de liberacion de droga